Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Paeshuyse

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Antibodies (Basel, Switzerland)|June 7, 2020
Construction of Antibody Phage Libraries and Their Application in Veterinary ImmunovirologyShahbaz Bashir, Jan Paeshuyse
Veterinary Medicine (Auckland, N.Z.)|May 31, 2023
Viral Protein 1 (VP1) Sequence-Based Genetic Diversity of SAT 2 FMDV Circulating in Ethiopia from 1990 to 2015Fanos Woldemariyam, Jan Paeshuyse
Current Opinion in Virology|March 24, 2012
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of actionJan Paeshuyse, Kai Dallmeier, Johan Neyts
Biochemical Pharmacology|August 14, 2012
The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replicationLeen Delang, Jan Paeshuyse, Johan Neyts
Antiviral Chemistry & Chemotherapy|December 21, 2011
Angiogenic activity of hepatitis B and C virusesKristof Vrancken, Jan Paeshuyse, Sandra Liekens
Journal of Infection and Public Health|March 22, 2024
CRISPR-Cas12/Cas13: Bibliometric analysis and systematic review of its application in infectious disease detectionSamson Leta, Tesfaye Rufael Chibssa, Jan Paeshuyse
Antiviral Research|November 21, 2017
Rational design of antiviral drug combinations based on equipotency using HCV subgenomic replicon as an in vitro modelMohamed Mandour, Inge Vliegen, Jan Paeshuyse, et al.
Veterinary Sciences|August 25, 2022
Molecular Characterization of ASFV and Differential Diagnosis of <i>Erysipelothrix</i> in ASFV-Infected Pigs in Pig Production Regions in CameroonEbanja Joseph Ebwanga, Stephen Mbigha Ghogomu, Jan Paeshuyse
Antiviral Research|June 4, 2015
In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistanceInge Vliegen, Jan Paeshuyse, Weidong Zhong, et al.
Antiviral Research|November 24, 2015
Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countriesHayat Khan, Jan Paeshuyse, Sheeba Murad, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Antibodies (Basel, Switzerland)|June 7, 2020
Construction of Antibody Phage Libraries and Their Application in Veterinary ImmunovirologyShahbaz Bashir, Jan Paeshuyse
Veterinary Medicine (Auckland, N.Z.)|May 31, 2023
Viral Protein 1 (VP1) Sequence-Based Genetic Diversity of SAT 2 FMDV Circulating in Ethiopia from 1990 to 2015Fanos Woldemariyam, Jan Paeshuyse
Current Opinion in Virology|March 24, 2012
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of actionJan Paeshuyse, Kai Dallmeier, Johan Neyts
Biochemical Pharmacology|August 14, 2012
The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replicationLeen Delang, Jan Paeshuyse, Johan Neyts
Antiviral Chemistry & Chemotherapy|December 21, 2011
Angiogenic activity of hepatitis B and C virusesKristof Vrancken, Jan Paeshuyse, Sandra Liekens
Journal of Infection and Public Health|March 22, 2024
CRISPR-Cas12/Cas13: Bibliometric analysis and systematic review of its application in infectious disease detectionSamson Leta, Tesfaye Rufael Chibssa, Jan Paeshuyse
Antiviral Research|November 21, 2017
Rational design of antiviral drug combinations based on equipotency using HCV subgenomic replicon as an in vitro modelMohamed Mandour, Inge Vliegen, Jan Paeshuyse, et al.
Veterinary Sciences|August 25, 2022
Molecular Characterization of ASFV and Differential Diagnosis of <i>Erysipelothrix</i> in ASFV-Infected Pigs in Pig Production Regions in CameroonEbanja Joseph Ebwanga, Stephen Mbigha Ghogomu, Jan Paeshuyse
Antiviral Research|June 4, 2015
In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistanceInge Vliegen, Jan Paeshuyse, Weidong Zhong, et al.
Antiviral Research|November 24, 2015
Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countriesHayat Khan, Jan Paeshuyse, Sheeba Murad, et al.
Pageof 9